China Shineway Pharmaceutical Group Limited
HKEx Stock Code: 02877 Chinese
Financial Reports
Interim Report  2018 2018
Interim Report
 
More  
Monthly Newsflash
2018 Oct Newsflash 2018
Oct Newsflash
 
More  
Financial Calendar
 
Reverse Roadshow
5 June 2018
 
  More
  China Shineway Pharmaceutical Group Limited is the largest Chinese medicine injection and soft capsule manufacturer in the PRC. Our shares are listed on the Main Board of Hong Kong Stock Exchange. Shineway is one of the Hang Seng Composite Index constituents and is named by Forbes Magazine as Asia's Best 200 Under a Billion.

Our products are primarily categorized into three major types: injection, soft capsule and granule, targeting three market segments with high growth potential, namely the middle and old aged, anti-viral and children, and are marketed under the "SHINEWAY" brand - a China Famous Trademark.
Latest News
Voluntary Announcement - Officially Commences Construction of TCM Formula Granules and TCM Healthcare Industrialization Complex in Gansu Province   29 Oct 2018
Announcements and Notices - Turnover for the Nine Months Ended 30 September 2018   26 Oct 2018
Announcements and Notices - 2018 Interim Results Announcement   31 Aug 2018
Product Highlight
 
Qingkailing Soft Capsules
Clearing away heat and toxins...
 
  More  
Related Links
Email Alerts
Industry Regulations
Shineway's China Website Related Website of Pharmaceutical Industry